この新しいレポートは、新たな検査、技術、機器、国別の売上予測、市場シェア、主要サプライヤーの戦略的プロフィールなど、日本の乱用薬物検査市場の包括的な分析を提供します。
今後5 年間で、乱用薬物検査市場は大きな変革を遂げるでしょう。これらの変化は、より厳格な新しい規制の収束、診断技術、システムエンジニアリング、自動化、ITの進歩、そして競争の激化によって引き起こされます。一部のセグメントはコモディティ市場に似てくるようになり、そこでは製品のポジショニングと検査あたりのコストが基礎となるテクノロジーよりも重要になります。この進化する市場は、さまざまな新しい機器、試薬システム、および標本調製装置、制御装置、キャリブレーターなどの補助製品に刺激的な機会を生み出すでしょう。
本レポートは、現在のサプライヤーや潜在的な市場参入者が、新たなビジネスチャンスを特定・評価し、効果的な戦略的対応策を策定するために作成されたユニークな調査です。本調査では、将来の動向を調査し、市場セグメント別、個別アッセイ別の検査量と売上高予測を提供しています。
目次
Table of Contents
Introduction
Market and Technology Overview
A. Major Drugs of Abuse
1. Overview
2. Test Methodologies
3. Amphetamines
4. Barbiturates
5. Benzodiazepines
6. Cannabinoids/Marijuana
7. Cocaine
8. Lysergic Acid Diethylamide (LSD)
9. Methadone
10. Methaqualone
11. Opiates
12. Phencyclidine
13. Tricyclic Antidepressants
B. Instrumentation Review: Operating characteristics and
features of high-, medium-, and low-volume/POC analyzers
manufactured by Abaxis, Abbott, Alere/Inverness,
Alfa Wassermann, AMS, Awareness Technologies, Beckman Coulter/Olympus,
Binding Site, bioMerieux, Carolina Chemistries, DiaSorin, Grifols, Horiba,
Medica, Nova Biomedical, Ortho-Clinical Diagnostics, Polymedco, Randox,
Roche, Siemens, Tosoh, Vital Diagnostics and other suppliers
C. Major In Vitro Diagnostic Technologies
And Their Potential Applications
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
a. Technological Principle
b. Chemiluminescence
c. Enzyme Immunoassays (EIA)
° Overview
° ELISA
° EMIT
° Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
3. Tandem Mass Spec
4. IT and Automation
5. Dry Chemistry
6. Biosensors
D. Market Size, Growth and Major Supplier Shares
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments
Abbott
Agilent Technologies
Beckman Coulter/Danaher
bioMerieux
Bio-Rad
DiaSorin
Eiken Chemical
Fujirebio
Grifols
Instrumentation Laboratory/Werfen
Kyowa Medex
Ortho-Clinical Diagnostics
PerkinElmer
Quest Diagnostics
Roche
Siemens Healthineers
Sysmex
Thermo Fisher
Tosoh
Wako
List of Tables
Major Companies Developing or Marketing
Drugs of Abuse Tests
Japan, Drugs of Abuse Test Volume
Forecast By Market Segment
Japan, All Market Segments, Drugs of Abuse
Test Volume Forecast by Assay
Japan, Hospital Laboratories, Drugs of Abuse
Test Volume Forecast by Assay
Japan, Commercial/Private Laboratories,
Drugs of Abuse Test Volume Forecast by Assay
Japan, Drugs of Abuse Reagent Market
Forecast By Market Segment
Japan, All Market Segments, Drugs of Abuse
Reagent Market Forecast by Assay
Japan, Hospital Laboratories, Drugs of Abuse
Reagent Market Forecast by Assay
Japan, Commercial/Private Laboratories,
Drugs of Abuse Reagent Market Forecast by Assay
Japan, Major Suppliers of Immunodiagnostic Products,
Estimated Market Share
